Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ABT
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Abbott Laboratories (ABT) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Abbott Laboratories (ABT) trades at $102.05, down 1.02% with strong analyst support (78% buy ratings) and a $121.50 consensus target. Recent FDA approval for the TactiFlex Duo catheter and consistent earnings beats in Q1 and Q2 2026 highlight operational strength, though Q4 2025 missed expectations. The stock shows bullish technical signals with RSI indicating potential oversold conditions, while fundamentals reveal solid profitability with 56.61% gross margins and improving debt-to-asset ratios.
The outlook remains positive given Abbott's innovation pipeline and institutional accumulation, but risks include the $384 million infant formula settlement and competitive pressures. Revenue growth to $46.6B in 2026 with 11.64% net margins supports long-term value, though current P/E of 33.13 demands execution on guidance. The stock presents a compelling buy case for growth-oriented investors seeking healthcare exposure.
Read full analysis

Key Stats

  • Market Cap
    $177.12B
  • Volume
    5,211,334
  • Sector
    Health
  • 52W High
    $136.62
  • 52W Low
    $82.57
  • Typical Hold Time
    96 Days
  • Enterprise Value
    $204.13B
  • Div Yield
    2.46%
  • Trading Activity
    97% Sell | 3% Buy
$101.28
52W Low: $82.57
11 May 2026
52W High: $136.62
22 Sep 2025

Track Abbott Laboratories (ABT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $136.62, highlighting its annual price range. Buy and sell Abbott Laboratories shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Most Recent News

Content is generated by Aura AI

Five Below CHRO Maureen Gellerman sells 1,610 shares for $401,000

Maureen Gellerman, Chief Human Resources Officer at Five Below, sold 1,610 shares of the company, generating $401,000 from the transaction. This insider sale may indicate personal financial planning or portfolio rebalancing but does not necessarily r...

Market News
3 hours ago
Jake Lerch
Neutral
Five Below CHRO Maureen Gellerman sells 1,610 shares for $401,000

ON Semiconductor drives AI and EV growth with new power tech and a 2030 vision despite neutral rating.

ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...

Market News
3 hours ago
Andrew Wynn
Bearish
news icon
ON Semiconductor drives AI and EV growth with new power tech and a 2030 vision despite neutral rating.

Couple quits jobs to travel for a year after winning millions from SpaceX IPO

Brian Aggrey and Phoebe Novack, who gained millions from SpaceX's record IPO, quit their jobs to fund a $25,000 monthly travel and hobby budget for a year. Aggrey, a former SpaceX employee of 14 years, accumulated significant stock that turned into a...

Market News
4 hours ago
New York Post
Bullish
news icon
Couple quits jobs to travel for a year after winning millions from SpaceX IPO
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $177.12B
  • Volume
    5,211,334
  • Sector
    Health
  • 52W High
    $136.62
  • 52W Low
    $82.57
  • Typical Hold Time
    96 Days
  • Enterprise Value
    $204.13B
  • Div Yield
    2.46%
  • Trading Activity
    97% Sell | 3% Buy
$101.28
52W Low: $82.57
11 May 2026
52W High: $136.62
22 Sep 2025

Track Abbott Laboratories (ABT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $136.62, highlighting its annual price range. Buy and sell Abbott Laboratories shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!